Your Organizational Guidance

ebpracticenet

Évaluation du risque cardiovasculaire en première ligne

Published by:Domus Medica

Last published:2010

Cardiovasculaire risicobepaling in de eerste lijn

Published by:Domus Medica

Last published:2020


International guidelines

Rest of the world

Consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance[38]

Published by:European Atherosclerosis Society

Last published:2023

Cardiovascular disease: risk assessment and reduction, including lipid modification[51]

Published by:National Institute for Health and Care Excellence (UK)

Last published:2023

2022 ACC Expert Consensus Decision Pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee​[56]

Published by:American College of Cardiology

Last published:2022

2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults[35]

Published by:Canadian Cardiovascular Society

Last published:2021

2021 ESC guidelines on cardiovascular disease prevention in clinical practice[58]

Published by:European Society of Cardiology

Last published:2021

​Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline[132]

Published by:Endocrine Society

Last published:2020

VA/DoD clinical practice guideline for the management of dyslipidemia for cardiovascular risk reduction[131]

Published by:Veterans Health Administration

Last published:2020

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the management of dyslipidemia and prevention of cardiovascular disease algorithm - 2020 executive summary​​[130]

Published by:American Association of Clinical Endocrinologists; American College of Endocrinology

Last published:2020

ACC/AHA guideline on the primary prevention of cardiovascular disease[59]

Published by:American College of Cardiology; American Heart Association

Last published:2019

Dietary cholesterol and cardiovascular risk: a science advisory from the American Heart Association[14]

Published by:American Heart Association

Last published:2019

2019 ESC/EAS guidelines for the management of dyslipidaemias[41]

Published by:European Society of Cardiology; European Atherosclerosis Society

Last published:2019

Familial hypercholesterolaemia: identification and management[55]

Published by:National Institute for Health and Care Excellence (UK)

Last published:2019

AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol[44]

Published by:American Heart Association; American College of Cardiology

Last published:2018

AHA/ACC/AACVPR/AAPA/ABC/ACPM/ ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol​​[44]

Published by:American Heart Association; American College of Cardiology

Last published:2018

Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease[53]

Published by:American Heart Association; American College of Cardiology

Last published:2018

AACE/ACE guidelines for management of dyslipidemia and prevention of cardiovascular disease[50]

Published by:American Association of Clinical Endocrinologists; American College of Endocrinology

Last published:2017

Global recommendations for the management of dyslipidemia[54]

Published by:International Atherosclerosis Society

Last published:2014

Use of this content is subject to our disclaimer